Affimed (NASDAQ:AFMD) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Affimed Stock Performance Shares of AFMD opened at $0.69 on Friday. The business’s 50 day moving average is $0.80 and its 200 day moving […]
StockNews.com began coverage on shares of Affimed (NASDAQ:AFMD – Free Report) in a research report sent to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Affimed Stock Performance Shares of AFMD opened at $0.69 on Friday. The business’s 50 day moving average is $0.80 and its 200 day moving […]
